Shanghai Yingrui Biopharma Co.,Ltd.
Home
About Us
ABOUT US
Corporate Culture
Products
APIs & Intermediates
PEG Derivatives
The others
Services
News
Company News
Industry Trends
Contact Us
NEWS CENTER
CAR-T therapy, a million-dollar cancer drug, breaks the ice in medical insurance coverage.
CAR-T drugs have always been known for their exorbitant prices, with each injection costing around 1 million yuan. The issue of CAR-T drugs being included in medical insurance has also received much attention. Now, this situation has finally made a breakthrough. It is reported that on September 20th, the National Healthcare Security Administration announced that the expert review of the first edition of the commercial insurance innovative drug catalog has been completed. Among them, all 5 CAR-T
2025-09-26
2025
09-26
In September, China's innovative drugs went global, adopting the NewCo model multiple times
NewCo may be a more suitable model for some domestic pharmaceutical companies than BD, which has been increasing from last year to this year. The fields of cancer and self immunotherapy are the main layout directions. Since September, there have been multiple incidents of NewCo going global.
2025-09-18
09-18
GLP-1 drugs receive another major boost
Recently, the World Health Organization (WHO) announced the inclusion of GLP-1 drugs and other essential medicines in its Essential Medicines List (EML), aiming to promote global accessibility of these high priced drugs. It is reported that the core active ingredients of Novo Nordisk Ozempic and Lilly Mounjaro are included in the list this time for the treatment of type 2 diabetes combined with cardiovascular disease, chronic kidney disease or obesity.
2025-09-08
09-08